We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Healthy Mice Born from Transplanted Wombs

By HospiMedica staff writers
Posted on 30 Jul 2003
Doctors and scientists in Sweden have transplanted uteri from one set of mice to another that then produced normal baby mice, which they state is the first time that live births have occurred in the transplanted uteri of any species. More...
The achievement was reported at the annual meeting of the European Society of Human Reproduction and Embryology in Madrid (Spain).

In each recipient mouse, the transplanted uterus was placed alongside the normal uterus, which served as a control. After transplantation between genetically identical mice, the grafted uterus produced baby mice. These had normal body weight, showed normal behavior, and were fertile. Five of seven uterine grafts that had been preserved in a cooling solution for 24 hours also produced healthy babies. Transplantation between different strains of mice was used to study rejection of the transplants. The researchers found that rejection progressed gradually from day two. By day 10, there was severe acute rejection and by day 15, there was necrosis and extensive scar tissue.

To minimize ischemia, organs were preserved in a cooling solution. The researchers preserved some of the uteri for 24 hours in UW (University of Wisconsin) solution or sodium chloride or for 48 hours in UW solution. The uteri preserved for 24 hours in UW solution still showed normal blood flow and histology two weeks after transplantation, but the graft transplanted after 48 hours showed impaired blood flow and by two weeks was necrotic. This demonstrated that the time limit for removing and transplanting the uterus was 24-48 hours.

"We think our findings have big implications for the development of womb transplants in women,” said team leader Mats Brannstrom, a professor at Sahlgrenska University (Goteborg, Sweden). "We've demonstrated for the first time that transplanted uteri can harbor pregnancies and that the rejection of the uterus is similar to other organs.” Prof. Brannstrom believes womb transplants could help 3-4% of infertile women and could be an alternative to surrogacy.




Related Links:
Sahlgrenska University

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.